Natural Alternatives International (NAII) Competitors $3.37 +0.09 (+2.74%) Closing price 04:00 PM EasternExtended Trading$3.32 -0.05 (-1.48%) As of 04:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NAII vs. ENTX, ORMP, KALA, IPA, OKYO, OVID, VXRT, WHWK, ATRA, and QNCXShould you be buying Natural Alternatives International stock or one of its competitors? The main competitors of Natural Alternatives International include Entera Bio (ENTX), Oramed Pharmaceuticals (ORMP), KALA BIO (KALA), ImmunoPrecise Antibodies (IPA), OKYO Pharma (OKYO), Ovid Therapeutics (OVID), Vaxart (VXRT), Whitehawk Therapeutics (WHWK), Atara Biotherapeutics (ATRA), and Quince Therapeutics (QNCX). These companies are all part of the "pharmaceutical products" industry. Natural Alternatives International vs. Its Competitors Entera Bio Oramed Pharmaceuticals KALA BIO ImmunoPrecise Antibodies OKYO Pharma Ovid Therapeutics Vaxart Whitehawk Therapeutics Atara Biotherapeutics Quince Therapeutics Natural Alternatives International (NASDAQ:NAII) and Entera Bio (NASDAQ:ENTX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation. Which has more volatility and risk, NAII or ENTX? Natural Alternatives International has a beta of 0.57, suggesting that its share price is 43% less volatile than the S&P 500. Comparatively, Entera Bio has a beta of 1.69, suggesting that its share price is 69% more volatile than the S&P 500. Does the media prefer NAII or ENTX? In the previous week, Entera Bio had 4 more articles in the media than Natural Alternatives International. MarketBeat recorded 5 mentions for Entera Bio and 1 mentions for Natural Alternatives International. Entera Bio's average media sentiment score of 1.25 beat Natural Alternatives International's score of 0.00 indicating that Entera Bio is being referred to more favorably in the news media. Company Overall Sentiment Natural Alternatives International Neutral Entera Bio Positive Do insiders and institutionals believe in NAII or ENTX? 32.4% of Natural Alternatives International shares are owned by institutional investors. Comparatively, 14.1% of Entera Bio shares are owned by institutional investors. 20.9% of Natural Alternatives International shares are owned by company insiders. Comparatively, 10.4% of Entera Bio shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Do analysts prefer NAII or ENTX? Entera Bio has a consensus price target of $10.00, indicating a potential upside of 437.63%. Given Entera Bio's stronger consensus rating and higher possible upside, analysts clearly believe Entera Bio is more favorable than Natural Alternatives International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natural Alternatives International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Entera Bio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 Which has better valuation & earnings, NAII or ENTX? Natural Alternatives International has higher revenue and earnings than Entera Bio. Entera Bio is trading at a lower price-to-earnings ratio than Natural Alternatives International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatural Alternatives International$113.80M0.18-$7.22M-$1.39-2.42Entera Bio$166K511.65-$9.54M-$0.26-7.15 Is NAII or ENTX more profitable? Natural Alternatives International has a net margin of -6.56% compared to Entera Bio's net margin of -4,525.11%. Natural Alternatives International's return on equity of -10.34% beat Entera Bio's return on equity.Company Net Margins Return on Equity Return on Assets Natural Alternatives International-6.56% -10.34% -5.19% Entera Bio -4,525.11%-77.75%-68.13% SummaryNatural Alternatives International and Entera Bio tied by winning 8 of the 16 factors compared between the two stocks. Get Natural Alternatives International News Delivered to You Automatically Sign up to receive the latest news and ratings for NAII and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NAII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAII vs. The Competition Export to ExcelMetricNatural Alternatives InternationalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$20.83M$2.64B$5.78B$10.04BDividend YieldN/A49.23%5.27%4.52%P/E Ratio-2.4223.7475.5726.08Price / Sales0.18501.55516.51171.66Price / CashN/A167.9837.2059.76Price / Book0.255.2711.536.20Net Income-$7.22M$32.95M$3.29B$270.65M7 Day Performance-7.16%1.34%0.44%2.77%1 Month Performance-8.92%30.71%10.84%8.83%1 Year Performance-47.75%2.03%61.62%27.49% Natural Alternatives International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAIINatural Alternatives International0.2028 of 5 stars$3.37+2.7%N/A-51.5%$20.83M$113.80M-2.42290Positive NewsENTXEntera Bio1.641 of 5 stars$1.99+2.8%$10.00+403.8%-0.5%$90.64M$180K-7.6320Short Interest ↓Gap UpORMPOramed Pharmaceuticals0.4639 of 5 stars$2.19-0.7%N/A-4.1%$89.59M$1.34M-6.2410Positive NewsGap DownKALAKALA BIO3.7199 of 5 stars$12.71+13.3%$13.00+2.3%+135.3%$89.29M$3.89M-1.8730News CoverageAnalyst ForecastHigh Trading VolumeIPAImmunoPrecise Antibodies2.5573 of 5 stars$1.91-19.4%$4.00+109.4%+220.8%$88.15M$17.59M-2.8180Upcoming EarningsGap UpOKYOOKYO Pharma2.5906 of 5 stars$2.34-0.4%$7.00+199.1%+117.3%$87.22MN/A0.007Positive NewsOVIDOvid Therapeutics4.3271 of 5 stars$1.22-5.1%$3.10+155.1%+15.9%$86.40M$570K-2.2960VXRTVaxart2.0847 of 5 stars$0.37-4.4%$2.00+436.2%-57.6%$85.39M$47.40M-1.38120News CoverageGap UpWHWKWhitehawk TherapeuticsN/A$1.80-0.3%N/AN/A$84.83M$25.98M-30.0040Positive NewsATRAAtara Biotherapeutics4.4478 of 5 stars$11.98-0.6%$21.00+75.4%+33.1%$84.06M$128.94M-27.85330Positive NewsQNCXQuince Therapeutics3.3986 of 5 stars$1.56-2.5%$8.14+422.0%+130.0%$83.57MN/A-1.4360Positive News Related Companies and Tools Related Companies Entera Bio Competitors Oramed Pharmaceuticals Competitors KALA BIO Competitors ImmunoPrecise Antibodies Competitors OKYO Pharma Competitors Ovid Therapeutics Competitors Vaxart Competitors Whitehawk Therapeutics Competitors Atara Biotherapeutics Competitors Quince Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NAII) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredPOP QUIZ: What’s the #1 indicator of a stock’s success? (Nope, not earnings or sales)What indicator do you think is the #1 predictor of stock market success? Most would guess earnings or sales...The Oxford Club | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThis stock just surpassed PalantirThe media hasn't caught up to the story yet, but when they do, this stock could leave Nvidia in the dust. I...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natural Alternatives International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Natural Alternatives International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NAII Stock Alerts